Bruker (BRKR) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BRKR Hot Sheet
Financial Fact:
Selling, general and administrative: 96.8M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.42, $0.11 better than the analyst estimate of $0.31. Revenue for the quarter came in at $511.4 million versus the consensus estimate of $483.68 million.
Guidance Remains Suspended
Bruker’s FY 2020 financial guidance remains suspended. Bruker expects that the pandemic and related economic slowdown will continue to have a negative year-over-year impact on the Company’s fourth quarter 2020 financial results.
For earnings history and earnings-related data on Bruker (BRKR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phoenix Education Partners (PXED) PT Lowered to $32 at Jefferies
- Contineum Therapeutics (CTNM) PT Lowered to $23 at Stifel
- Qualcomm stock climbs after SpaceX 5G network deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
